Inventor · disambiguated record
Emilio Roldan
Also filed as: ROLDAN EMILIO · ROLDAN EMILIO J A
6 granted patents·4 pending applications·45 citations·filing 1995–2018
80Inventor score
Top patents by PatentIndex Score
10 records- 0171US7560490B2Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereofGADOR SA·Filed 2001·Granted Jul 14, 2009·10 cites·11 claims
- 0265US7846474B2Use of bisphosphonates for the treatment of osteogenesis imperfectaGADOR SA·Filed 2008·Granted Dec 7, 2010·0 cites·10 claims
- 0362US6864228B1Use of bisphosphonates for the treatment of osteogenesis imperfectaGADOR SA·Filed 2000·Granted Mar 8, 2005·3 cites·15 claims
- 0454US5885973ABone mass anabolic composition comprising olpadronateGADOR SA·Filed 1995·Granted Mar 23, 1999·23 cites·16 claims
- 0551US8853187B2Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereofZANETTI DANIEL·Filed 2009·Granted Oct 7, 2014·0 cites·19 claims
- 0646US2005026870A1Use of bisphosphonates for the treatment of osteogenesis imperfectaFiled 2004·Application pending·0 cites
- 0744US6605603B1Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acidGADOR SA·Filed 1999·Granted Aug 12, 2003·9 cites·3 claims
- 0844US2007270388A1Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acidROLDAN EMILIO J A·Filed 2007·Application pending·0 cites
- 0939US2021322329A1Nanostructured nanoparticles comprising one or more active ingredients for the treatment of diseases caused by trypanosomes and for the treatment of tumours of neural origin, compositions comprising same, a preparation method and therapeutic use thereofGADOR LTDA·Filed 2018·Application pending·0 cites
- 1038US2004023931A1Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acidFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emilio Roldan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →